[Characteristics of hematological malignancies in the elderly].
Ohta
Masatsugu
M
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000617:Aminoglycosides / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003072:Cognition Disorders; D003153:Community Health Services; D019317:Evidence-Based Medicine; D000079982:Gemtuzumab; D015316:Genetic Therapy; D019337:Hematologic Neoplasms / Q000145:classification / Q000523:psychology / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007258:Informed Consent; D010348:Patient Care Team; D011788:Quality of Life; D019172:Transplantation Conditioning
D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab